Disease Info Card

Hepatic Insufficiency

Information about Hepatic Insufficiency: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Hepatic Insufficiency

Most recent studies have shown that Hepatic Insufficiency shares some biological mechanisms with carcinoma, cholestasis, encephalopathies, hemorrhage, hepatic-encephalopathy, hepatitis, hypertension-portal, hypertensive-disease, icterus, kidney-failure, liver-carcinoma, liver-cirrhosis, liver-diseases, liver-failure, liver-failure-acute, liver-neoplasms, malignant-neoplasms, neoplasm-metastasis, neoplasms, renal-insufficiency.

Among the many pathways, these few ones have gauged particular interests from scientists studying Hepatic Insufficiency, and have been seen in publications frequently: Aging, Blood Coagulation, Cell Death, Coagulation, Diuresis, Excretion, Fibrinolysis, Glomerular Filtration, Gluconeogenesis, Hemostasis, Inflammatory Response, Liver Regeneration, Localization, Pathogenesis, Platelet Aggregation, Regeneration, Secretion, Transport, Urea Cycle, Vasoconstriction

Quite a number of genes have been found to play important roles in Hepatic Insufficiency, such as AFP, AGT, ALB, BCHE, CP, CYP3A4, F2, GCG, GGT1, GLUL, IL6, INS, KLK3, SERPINC1, SLA2, SLC17A5, TRIM26. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.